Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis ; volume:15 ; number:1 ; day:19 ; month:6 ; year:2017 ; pages:1-6 ; date:12.2017
Pediatric rheumatology ; 15, Heft 1 (19.6.2017), 1-6, 12.2017
- Schlagwort
-
Pädiatrie
Kinderkrankheit
- Urheber
-
Falvey, Sonja
- Beteiligte Personen und Organisationen
-
Shipman, Lauren
Ilowite, Norman
Beukelman, Timothy
SpringerLink (Online service)
- DOI
-
10.1186/s12969-017-0180-2
- URN
-
urn:nbn:de:1111-201709106718
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Falvey, Sonja
- Shipman, Lauren
- Ilowite, Norman
- Beukelman, Timothy
- SpringerLink (Online service)
Ähnliche Objekte (12)
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance